Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Indolfi

Showing results (191-200 of 330) with videos related to

Pageof 33
Sort By:
Scientific Reports|April 13, 2021
Abnormal myocardial work in children with Kawasaki diseaseJolanda Sabatino, Nunzia Borrelli, Alain Fraisse, et al.
Basic Research in Cardiology|March 4, 2011
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophyGiovanni Esposito, Cinzia Perrino, Alessandro Cannavo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of CardiologyFrancesco Barillà, Francesco Pelliccia, Mauro Borzi, et al.
Journal of the American College of Cardiology|September 6, 2005
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart diseaseFerdinando Carlo Sasso, Daniele Torella, Ornella Carbonara, et al.
Circulation|October 16, 2002
Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activationCiro Indolfi, Emilio Di Lorenzo, Cinzia Perrino, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[GISE (Italian Society of Interventional Cardiology) Position paper: Short-term hospitalization for percutaneous coronary intervention; a helpful tool to manage post-COVID-19 backlogs]Roberto Violini, Salvatore De Rosa, Sergio Leonardi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 27, 2018
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISECiro Indolfi, Antonio L Bartorelli, Sergio Berti, et al.
British Journal of Pharmacology|April 16, 2020
The role of mitochondrial dynamics in cardiovascular diseasesMaurizio Forte, Leonardo Schirone, Pietro Ameri, et al.
Scientific Reports|January 17, 2018
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid ArterySabato Sorrentino, Claudio Iaconetti, Salvatore De Rosa, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 15, 2023
Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammationGiovanni Cimmino, Saverio Muscoli, Salvatore De Rosa, et al.
Pageof 33

Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
Scientific Reports|April 13, 2021
Abnormal myocardial work in children with Kawasaki diseaseJolanda Sabatino, Nunzia Borrelli, Alain Fraisse, et al.
Basic Research in Cardiology|March 4, 2011
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophyGiovanni Esposito, Cinzia Perrino, Alessandro Cannavo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of CardiologyFrancesco Barillà, Francesco Pelliccia, Mauro Borzi, et al.
Journal of the American College of Cardiology|September 6, 2005
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart diseaseFerdinando Carlo Sasso, Daniele Torella, Ornella Carbonara, et al.
Circulation|October 16, 2002
Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activationCiro Indolfi, Emilio Di Lorenzo, Cinzia Perrino, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[GISE (Italian Society of Interventional Cardiology) Position paper: Short-term hospitalization for percutaneous coronary intervention; a helpful tool to manage post-COVID-19 backlogs]Roberto Violini, Salvatore De Rosa, Sergio Leonardi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 27, 2018
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISECiro Indolfi, Antonio L Bartorelli, Sergio Berti, et al.
British Journal of Pharmacology|April 16, 2020
The role of mitochondrial dynamics in cardiovascular diseasesMaurizio Forte, Leonardo Schirone, Pietro Ameri, et al.
Scientific Reports|January 17, 2018
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid ArterySabato Sorrentino, Claudio Iaconetti, Salvatore De Rosa, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 15, 2023
Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammationGiovanni Cimmino, Saverio Muscoli, Salvatore De Rosa, et al.
Pageof 33